Monday, June 15, 2026

MSD Korea Announced at Bio Korea 2026 that Korea is a Crucial Hub for Global Innovation

Korea is now a key innovation hub for MSD, focusing on neuroscience and clinical research collaborations, with significant R&D investments.

Europe Moves to Ease Biosimilar Rules, Boosting Asia’s Biopharma Giants

EMA's new guidelines aim to simplify biosimilar development, boosting Samsung Bioepis and Celltrion in Europe's growing market.

Hyundai: Trump’s 25% Tariff Talk Pushes a $5B U.S. Robot Factory Bet—Smart Hedge for 2026?

Analysts predict Trump's tariff focus may boost Hyundai's U.S. investments, despite uncertainty and potential operating losses.

Tag: Kim Min Ha

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

No posts to display

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.